For media inquiries,
please contact:
Katie Engleman
Pure Communications Inc.
(910) 509-3977

Press Releases

October 4, 2012
Ember Therapeutics Broadens Brown Fat Small Molecule Drug Discovery Portfolio, Secures Exclusive License Options to Intellectual Property for Three Small Molecule Targets

September 27, 2012
Ember Therapeutics Announces Cell Publication of Key Data Showing TRPV4 Inhibition Activates Brown/Beige Fat and Protects Against Obesity, Inflammation and Insulin Resistance

July 13, 2012
Ember Therapeutics Announces Cell Publication of Key Beige Fat Discovery; Technology Licensed from the Dana-Farber Cancer Institute

May 30, 2012
Ember Therapeutics Expands Scientific Leadership To Advance Metabolic Pipeline

March 28, 2012
Ember Therapeutics Secures Exclusive License to Key Brown Fat Technology and Intellectual Property from the Joslin Diabetes Center

January 11, 2012
Ember Announces Nature Publication of Brown Fat Biology Data; Program Exclusively Licensed from the Dana-Farber Cancer Institute

December 15, 2011
Third Rock Ventures Launches Ember Therapeutics to Address Critical Need for Novel Treatments for Metabolic Disease